FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.7  |  FHIR Version n/a  User: [n/a]

19338005: deux (valeur de l'attribut)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
32597014 Two en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
33051000077117 deux fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)
3442102012 2 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3442103019 2 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
614921000077110 deux (valeur de l'attribut) fr Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)
747350014 Two (qualifier value) en Fully specified name Inactive Only initial character case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
deux est un(e) (attribut) modificateur adjectival général false Inferred relationship Some
deux est un(e) (attribut) nombre true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Ethinyl estradiol 5 microgram and norethindrone acetate 1 mg oral tablet Count of base of active ingredient False deux Inferred relationship Some
Diphenhydramine 25 mg and ibuprofen 200 mg oral capsule Count of base of active ingredient False deux Inferred relationship Some
Product containing precisely hydrochlorothiazide 12.5 milligram and metoprolol tartrate 50 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
Ethinyl estradiol 20 microgram and norethindrone acetate 1 mg oral tablet Count of base of active ingredient False deux Inferred relationship Some
Product containing precisely levothyroxine sodium 100 microgram and liothyronine sodium 25 microgram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
Product containing precisely ethinylestradiol 30 microgram and norethisterone acetate 1.5 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
Hydrochlorothiazide 15 mg and methyldopa 250 mg oral tablet Count of base of active ingredient False deux Inferred relationship Some
Homatropine methylbromide 1.5 mg and hydrocodone bitartrate 5 mg oral tablet Count of base of active ingredient False deux Inferred relationship Some
Acetaminophen 500 mg and hydrocodone bitartrate 2.5 mg oral tablet Count of base of active ingredient False deux Inferred relationship Some
Product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 6 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
Drospirenone 2 mg and estradiol 1 mg oral tablet Count of base of active ingredient False deux Inferred relationship Some
Product containing precisely omeprazole 40 milligram and sodium bicarbonate 1.1 gram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 10 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
Pyrimethamine 25 mg and sulfadoxine 500 mg oral tablet Count of base of active ingredient False deux Inferred relationship Some
Acetaminophen 400 mg and hydrocodone bitartrate 5 mg oral tablet Count of base of active ingredient False deux Inferred relationship Some
Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
Glipizide 5 mg and metformin hydrochloride 500 mg oral tablet Count of base of active ingredient False deux Inferred relationship Some
Ibuprofen 400 mg and oxycodone 5 mg oral tablet Count of base of active ingredient False deux Inferred relationship Some
Product containing precisely hydralazine hydrochloride 100 milligram and hydrochlorothiazide 50 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
Eprosartan mesylate 600 mg and hydrochlorothiazide 25 mg oral tablet Count of base of active ingredient False deux Inferred relationship Some
Levothyroxine sodium 50 microgram and liothyronine sodium 12.5 microgram oral tablet Count of base of active ingredient False deux Inferred relationship Some
Drospirenone 500 microgram and estradiol 1 mg oral tablet Count of base of active ingredient False deux Inferred relationship Some
Product containing precisely fluoxetine hydrochloride 50 milligram and olanzapine 12 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
Product containing precisely hydralazine hydrochloride 25 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
Eprosartan mesylate 600 mg and hydrochlorothiazide 12.5 mg oral tablet Count of base of active ingredient False deux Inferred relationship Some
Product containing precisely levothyroxine sodium 12.5 microgram and liothyronine sodium 3.1 microgram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
Product containing precisely hydralazine hydrochloride 50 milligram and hydrochlorothiazide 50 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
Product containing precisely furosemide 40 milligram and triamterene 50 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
Product containing precisely naproxen sodium 500 milligram and sumatriptan succinate 85 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
Levothyroxine sodium 150 microgram and liothyronine sodium 37.5 microgram oral tablet Count of base of active ingredient False deux Inferred relationship Some
Furosemide 20 mg and spironolactone 50 mg oral capsule Count of base of active ingredient False deux Inferred relationship Some
Ethinyl estradiol 20 microgram and levonorgestrel 90 microgram oral tablet Count of base of active ingredient False deux Inferred relationship Some
Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil fumarate 136 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
Acetaminophen 660 mg and hydrocodone bitartrate 10 mg oral tablet Count of base of active ingredient False deux Inferred relationship Some
Lopinavir 133.3 mg and ritonavir 33.3 mg oral capsule Count of base of active ingredient False deux Inferred relationship Some
Loratadine 10 mg and pseudoephedrine sulfate 240 mg oral tablet Count of base of active ingredient False deux Inferred relationship Some
Product containing precisely ferrous fumarate 305 milligram and folic acid 350 microgram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
Product containing precisely fluoxetine hydrochloride 50 milligram and olanzapine 6 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
Product containing precisely ferrous fumarate 322 milligram and folic acid 350 microgram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
Hydrochlorothiazide 25 mg and labetalol hydrochloride 300 mg oral tablet Count of base of active ingredient False deux Inferred relationship Some
Product containing precisely glimepiride 1 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
Product containing precisely pethidine hydrochloride 50 milligram and promethazine hydrochloride 25 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength numerator value (attribute) False deux Inferred relationship Some 1
céfoxitine 2 g, pour injection (poudre pour reconstitution) (médicament clinique) Has presentation strength numerator value (attribute) False deux Inferred relationship Some 1
amoxicilline et clavulanate de potassium 1 mg/200 mg, fiole de poudre pour solution injectable (médicament clinique) Count of base of active ingredient False deux Inferred relationship Some
aztréonam 2 g, fiole de poudre pour solution injectable (médicament clinique) Has presentation strength numerator value (attribute) False deux Inferred relationship Some 1
Product containing precisely aspirin DL-lysine 900 milligram and metoclopramide hydrochloride 10 milligram/1 sachet conventional release oral powder (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
Product containing precisely benorilate 2 gram/1 sachet granules for conventional release oral suspension (clinical drug) Has presentation strength numerator value (attribute) False deux Inferred relationship Some 1
amoxicilline et clavulanate de potassium 500 mg/100 mg, fiole de poudre pour solution injectable (médicament clinique) Count of base of active ingredient False deux Inferred relationship Some
Deferoxamine mesylate 2 g powder for solution for injection vial Has presentation strength numerator value (attribute) False deux Inferred relationship Some 1
ampicilline et floxacilline 250 mg/250 mg, fiole de poudre pour solution injectable (médicament clinique) Count of base of active ingredient False deux Inferred relationship Some
ceftazidime 2 g, pour injection (poudre pour reconstitution) (médicament clinique) Has presentation strength numerator value (attribute) False deux Inferred relationship Some 1
ceftriaxone 2 g, pour injection (poudre pour reconstitution) (médicament clinique) Has presentation strength numerator value (attribute) False deux Inferred relationship Some 1
cefpirome 2 g, fiole de poudre pour solution injectable (médicament clinique) Has presentation strength numerator value (attribute) False deux Inferred relationship Some 1
Ifosfamide 2 g powder for solution for injection vial Has presentation strength numerator value (attribute) False deux Inferred relationship Some 1
pipéracilline 4 g/tazobactam 500 mg, fiole de poudre pour solution injectable (médicament clinique) Count of base of active ingredient False deux Inferred relationship Some
quinupristine 150 mg et dalfopristine 350 mg, fiole de poudre pour perfusion Count of base of active ingredient False deux Inferred relationship Some
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
Product containing precisely codeine phosphate 60 milligram and paracetamol 1 gram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
Remifentanil (as remifentanil hydrochloride) 2 mg powder for solution for injection vial Has presentation strength numerator value (attribute) False deux Inferred relationship Some 1
Acetaminophen 500 mg and metoclopramide hydrochloride 5 mg effervescent powder for oral suspension sachet Count of base of active ingredient False deux Inferred relationship Some
Raltitrexed 2 mg powder for solution for injection vial Has presentation strength numerator value (attribute) False deux Inferred relationship Some 1
Cilastatin (as cilastatin sodium) 500 mg and imipenem (as imipenem monohydrate) 500 mg powder for suspension for injection vial Count of base of active ingredient False deux Inferred relationship Some
Product containing precisely ispaghula husk 3.5 gram and mebeverine hydrochloride 135 milligram/1 sachet granules for conventional release oral suspension (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
Somatropin(rbe) 2 mg powder for solution for injection syringe Has presentation strength numerator value (attribute) False deux Inferred relationship Some 1
ticarcilline 3 g/acide clavulanique 200 mg, fiole de poudre pour perfusion (médicament clinique) Count of base of active ingredient False deux Inferred relationship Some
Magnesium alginate 87.5 mg and sodium alginate 225 mg powder for oral suspension sachet Count of base of active ingredient False deux Inferred relationship Some
Galactose 2.49 g and palmitic acid 2.5 mg powder for suspension for injection vial Count of base of active ingredient False deux Inferred relationship Some
Galactose 3.99 g and palmitic acid 4 mg powder for suspension for injection vial Count of base of active ingredient False deux Inferred relationship Some
Mitomycin 2 mg powder for solution for injection vial Has presentation strength numerator value (attribute) False deux Inferred relationship Some 1
pipéracilline 2 g/tazobactam 250 mg, fiole de poudre pour solution injectable (médicament clinique) Has presentation strength numerator value (attribute) False deux Inferred relationship Some 2
pipéracilline 2 g/tazobactam 250 mg, fiole de poudre pour solution injectable (médicament clinique) Count of base of active ingredient False deux Inferred relationship Some
Product containing precisely dantron 10 milligram/1 milliliter and docusate sodium 12 milligram/1 milliliter conventional release oral suspension (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
Dihydrocodeine tartrate 2 mg/mL oral solution Has concentration strength numerator value (attribute) False deux Inferred relationship Some 1
Ferric ammonium citrate 16 mg/mL and folic acid 500 microgram/mL oral solution Count of base of active ingredient False deux Inferred relationship Some
Ferric ammonium citrate 16 mg/mL and folic acid 100 microgram/mL oral solution Count of base of active ingredient False deux Inferred relationship Some
Product containing precisely hydroxyzine hydrochloride 2 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength numerator value (attribute) False deux Inferred relationship Some 1
Metaproterenol sulfate 2 mg/mL oral solution Has concentration strength numerator value (attribute) False deux Inferred relationship Some 1
Diazepam 2 mg/mL oral suspension Has concentration strength numerator value (attribute) False deux Inferred relationship Some 1
Product containing precisely dantron 15 milligram/1 milliliter and poloxamer 188 200 milligram/1 milliliter conventional release oral suspension (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
Product containing precisely amoxicillin (as amoxicillin trihydrate) 50 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 12.5 milligram/1 milliliter conventional release oral suspension (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
Diphenhydramine hydrochloride 2 mg/mL oral solution Has concentration strength numerator value (attribute) False deux Inferred relationship Some 1
Product containing precisely morphine sulfate 2 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength numerator value (attribute) False deux Inferred relationship Some 1
Sulfamethoxazole 80 mg/mL and trimethoprim 16 mg/mL oral suspension Count of base of active ingredient False deux Inferred relationship Some
Product containing precisely prednisolone 2 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength numerator value (attribute) False deux Inferred relationship Some 1
Product containing precisely paroxetine (as paroxetine hydrochloride) 2 milligram/1 milliliter conventional release oral suspension (clinical drug) Has concentration strength numerator value (attribute) False deux Inferred relationship Some 1
Dried aluminium hydroxide gel 44 mg/mL and magnesium hydroxide 39 mg/mL oral suspension Count of base of active ingredient False deux Inferred relationship Some
Product containing precisely spironolactone 2 milligram/1 milliliter conventional release oral suspension (clinical drug) Has concentration strength numerator value (attribute) False deux Inferred relationship Some 1
Dried aluminium hydroxide gel 120 mg/mL and magnesium hydroxide 60 mg/mL oral suspension Count of base of active ingredient False deux Inferred relationship Some
Ampicillin (as ampicillin trihydrate) 25 mg/mL and floxacillin (as floxacillin magnesium) 25 mg/mL oral suspension Count of base of active ingredient False deux Inferred relationship Some
Product containing precisely methadone hydrochloride 2 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength numerator value (attribute) False deux Inferred relationship Some 1
Pholcodine 2 mg/mL oral solution Has concentration strength numerator value (attribute) False deux Inferred relationship Some 1
Product containing precisely periciazine 2 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength numerator value (attribute) False deux Inferred relationship Some 1
Product containing precisely amoxicillin (as amoxicillin trihydrate) 25 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 6.25 milligram/1 milliliter conventional release oral suspension (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
Dicyclomine hydrochloride 2 mg/mL oral solution Has concentration strength numerator value (attribute) False deux Inferred relationship Some 1
Product containing precisely lopinavir 80 milligram/1 milliliter and ritonavir 20 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
Clorquinaldol 30 mg/g and hydrocortisone butyrate 1 mg/g cutaneous ointment Count of base of active ingredient False deux Inferred relationship Some
Product containing precisely phenothrin 2 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) Has concentration strength numerator value (attribute) False deux Inferred relationship Some 1
Midazolam (as midazolam hydrochloride) 2 mg/mL oral solution Has concentration strength numerator value (attribute) False deux Inferred relationship Some 1
Clorquinaldol 30 mg/g and hydrocortisone butyrate 1 mg/g cutaneous cream Count of base of active ingredient False deux Inferred relationship Some
Product containing precisely sodium fluoride 2 milligram/1 gram conventional release oromucosal solution (clinical drug) Has concentration strength numerator value (attribute) False deux Inferred relationship Some 1

Start Previous Page 21 of 24 Next End

This concept is not in any reference sets

Back to Start